MedTrace Logo

Montelukast in Chronic Asthma

NCT00802789 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2022-02-18

No results posted yet for this study

Summary

Treatment of patients insufficiently treated with ICS or ICS + LABA.

Conditions

Sponsors & Collaborators

  • Organon and Co

    lead INDUSTRY

Principal Investigators

  • Medical Monitor · Merck Sharp & Dohme LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2008-09-30
Completion
2008-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00802789 on ClinicalTrials.gov